Orion Oyj

Pharmaceuticals

ORNBV.HE

€ 37 (0.05)%

Share price

$ 5.6 bn

Market Cap

$ 5.7 bn

Enterprise Value

Carbon footprint

GHG emissions per $ 1 mln investment

0.11x the weighted average for S&P 500

FY2021

Primary Climate Goal

Proj. YOY change in GHG emissions (Scope 1 + 2)

Stronger than the -9.3% weighted average for S&P 500

FY2022

Orion Oyj aims to reduce Scope 1 + 2 by 75% by 2025 from a base year 2016

This target has not been verified as science based according to SBTi

GHG emissions and Carbon intensity

Orion Oyj reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2021 at 21 Kt (+2/+10% y-o-y). Carbon intensity also was up at 17 t (+1.9/+13% y-o-y).

Orion Oyj reported Scope 3 emissions for the the twelve months ending31 December 2021 at 554

The company is committed to reducing Scope 1 + 2 by 75% by 2025 from a base year 2016, which translates into the estimated reduction of -2.4 Kt per annum over the period of FY2022 - FY2025. This target, however, has not been recognised as science-based (and as aligned with Paris Agreement) by the SBTi.

Date	Total CO2e emissions (market-based Scope 1 & 2) (Kt)	Scope 1	Scope 2	Scope 3	Revenue (USDm)	Carbon intensity (tons of CO2e) / (USDm)
2021Q4	21	4.4	16	554	1,236	17
2020Q4	19	3.1	16		1,262	15
2019Q4	20	2.8	17		1,181	17
2018Q4	40	2.8	37		1,156	34
2017Q4	45	3.1	42		1,167	38
2016Q4	44	3.1	41		1,183	38
2015Q4	41	0.13	41		1,138	37

Orion Oyj

Carbon footprint

Primary Climate Goal

Orion Oyj aims to reduce Scope 1 + 2 by 75% by 2025 from a base year 2016

GHG emissions and Carbon intensity

Orion Oyj's carbon footprint

Company environmental metrics